» Articles » PMID: 29683801

Social, Economic, and Policy Implications of Organ Preservation Advances

Overview
Specialty General Surgery
Date 2018 Apr 24
PMID 29683801
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Despite over 60 years of progress in the field of since the first organ transplant, insufficient organ preservation capabilities still place profound constraints on transplantation. These constraints play multiple and compounding roles in the predominant limitations of the field: the severe shortages of transplant organs, short-term and long-term posttransplant outcomes and complications, the unmet global need for development of transplant infrastructures, and economic burdens that limit patient access to transplantation and contribute to increasing global healthcare costs. This review surveys ways that advancing preservation technologies can play a role in each of these areas, ultimately benefiting thousands if not millions of patients worldwide.

Recent Findings: Preservation advances can create a wide range of benefits across many facets of organ transplantation, as well as related areas of transplant research. As these technologies mature, so will the policies around their use to maximize the benefits offered by organ preservation.

Summary: Organ preservation advances stand to increase local and global access to transplantation, improve transplant outcomes, and accelerate progress in related areas such as immune tolerance induction and xenotransplantation. This area holds the potential to save the healthcare system many billions of dollars and reduce costs across many aspects of transplantation. Novel preservation technologies, along with other technologies facilitated by preservation advances, could potentially save millions of lives in the coming years.

Citing Articles

Governing new technologies that stop biological time: Preparing for prolonged biopreservation of human organs in transplantation.

Pruett T, Wolf S, McVan C, Lyon P, Capron A, Childress J Am J Transplant. 2024; 25(2):269-276.

PMID: 39306279 PMC: 11772108. DOI: 10.1016/j.ajt.2024.09.017.


Women Who Perform Social Egg Freezing as Moral Pioneers: The Case of Ultra-Orthodox Communities in Israel.

Maor M, Billig M J Relig Health. 2024; 63(4):2581-2598.

PMID: 38782858 PMC: 11319610. DOI: 10.1007/s10943-024-02062-z.


Myostatin Overexpression and Smad Pathway in Detrusor Derived from Pediatric Patients with End-Stage Lower Urinary Tract Dysfunction.

Salemi S, Schori L, Gerwinn T, Horst M, Eberli D Int J Mol Sci. 2023; 24(5).

PMID: 36901894 PMC: 10003571. DOI: 10.3390/ijms24054462.


Pre-Treatment of Transplant Donors with Hydrogen Sulfide to Protect against Warm and Cold Ischemia-Reperfusion Injury in Kidney and Other Transplantable Solid Organs.

McFarlane L, Nelson P, Dugbartey G, Sener A Int J Mol Sci. 2023; 24(4).

PMID: 36834928 PMC: 9963309. DOI: 10.3390/ijms24043518.


Temporal Dynamics of Metabolic Acquisition in Grafted Engineered Human Liver Tissue.

Fortin C, McCray T, Saxton S, Johansson F, Andino C, Mene J Adv Biol (Weinh). 2022; 7(5):e2200208.

PMID: 36328790 PMC: 10259871. DOI: 10.1002/adbi.202200208.


References
1.
Limkemann A, Lindell S, Reichstetter H, Plant V, Parrish D, Ramos C . Donor gluconate rescues livers from uncontrolled donation after cardiac death. Surgery. 2015; 159(3):852-61. PMC: 4744557. DOI: 10.1016/j.surg.2015.10.022. View

2.
Israni A, Zaun D, Bolch C, Rosendale J, Schaffhausen C, Snyder J . OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation. Am J Transplant. 2017; 17 Suppl 1:503-542. DOI: 10.1111/ajt.14131. View

3.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

4.
Landin L, Bonastre J, Casado-Sanchez C, Diez J, Ninkovic M, Lanzetta M . Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review. Transpl Int. 2012; 25(4):424-32. DOI: 10.1111/j.1432-2277.2012.01433.x. View

5.
Boucek M, Mashburn C, Dunn S, Frizell R, Edwards L, Pietra B . Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med. 2008; 359(7):709-14. DOI: 10.1056/NEJMoa0800660. View